Literature DB >> 3500328

T-cell responses to human immunodeficiency virus (HIV) and its recombinant antigens in HIV-infected chimpanzees.

J W Eichberg1, J M Zarling, H J Alter, J A Levy, P W Berman, T Gregory, L A Lasky, J McClure, K E Cobb, P A Moran.   

Abstract

Peripheral blood lymphocytes from chimpanzees infected for 3 months to more than 3 years with human immunodeficiency virus (HIV) had normal T-cell proliferative responses after stimulation with a variety of recall antigens and mitogens, indicating that HIV infection does not cause detectable immunological impairment in chimpanzees. This finding contrasts with that obtained in HIV-infected humans, who often have impaired T-cell reactivity. Peripheral blood lymphocytes from most HIV-infected chimpanzees that were studied also had strong proliferative responses to purified HIV as well as to HIV envelope glycoproteins isolated from the virus, to recombinant HIV envelope glycoproteins gp120 and gp41, and to HIV gag protein p24. The HIV-specific T-cell responses in HIV-infected chimpanzees may contribute to prevention of the development of acquired immunodeficiency syndrome in this species.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500328      PMCID: PMC255996          DOI: 10.1128/JVI.61.12.3804-3808.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins.

Authors:  J M Zarling; J W Eichberg; P A Moran; J McClure; P Sridhar; S L Hu
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

2.  Infection of chimpanzees with lymphadenopathy-associated virus.

Authors:  D P Francis; P M Feorino; J R Broderson; H M McClure; J P Getchell; C R McGrath; B Swenson; J S McDougal; E L Palmer; A K Harrison
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

3.  H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D.

Authors:  R M Zinkernagel; R M Welsh
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

4.  Transmission of HTLV-III infection from human plasma to chimpanzees: an animal model for AIDS.

Authors:  H J Alter; J W Eichberg; H Masur; W C Saxinger; R Gallo; A M Macher; H C Lane; A S Fauci
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

5.  Role of T-lymphocyte subsets in recovery from herpes simplex virus infection.

Authors:  H S Larsen; M F Feng; D W Horohov; R N Moore; B T Rouse
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

6.  Infection of chimpanzees by human T-lymphotropic retroviruses in brain and other tissues from AIDS patients.

Authors:  D C Gajdusek; H L Amyx; C J Gibbs; D M Asher; P Rodgers-Johnson; L G Epstein; P S Sarin; R C Gallo; A Maluish; L O Arthur
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

7.  The acquired immunodeficiency syndrome in a cohort of homosexual men. A six-year follow-up study.

Authors:  H W Jaffe; W W Darrow; D F Echenberg; P M O'Malley; J P Getchell; V S Kalyanaraman; R H Byers; D P Drennan; E H Braff; J W Curran
Journal:  Ann Intern Med       Date:  1985-08       Impact factor: 25.391

8.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

9.  Immunological characterizations of patients with acquired immune deficiency syndrome, acquired immune deficiency syndrome-related symptom complex, and a related life-style.

Authors:  E M Hersh; P W Mansell; J M Reuben; A Rios; G R Newell
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

10.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

View more
  14 in total

Review 1.  Why clinical trials of AIDS vaccines are premature.

Authors:  W K Mariner
Journal:  Am J Public Health       Date:  1989-01       Impact factor: 9.308

2.  Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines.

Authors:  P W Berman; W M Nunes; O K Haffar
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

3.  Synthetic peptides define the fine specificity of the human immunodeficiency virus (HIV) gp160 humoral immune response in HIV type 1-infected chimpanzees.

Authors:  R Q Warren; H Wolf; K R Shuler; J W Eichberg; R A Zajac; R N Boswell; P Kanda; R C Kennedy
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

4.  Virus-specific cytotoxic T lymphocytes in human immunodeficiency virus type 1-infected chimpanzees.

Authors:  S Santra; P N Fultz; N L Letvin
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

5.  Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus.

Authors:  M L Poss; J I Mullins; E A Hoover
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

6.  High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees.

Authors:  K Saksela; E Muchmore; M Girard; P Fultz; D Baltimore
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  T- and B-lymphocyte responses to human immunodeficiency virus (HIV) type 1 in macaques immunized with hybrid HIV/hepatitis B surface antigen particles.

Authors:  M L Michel; M Mancini; Y Riviere; D Dormont; P Tiollais
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120.

Authors:  P W Berman; J E Groopman; T Gregory; P R Clapham; R A Weiss; R Ferriani; L Riddle; C Shimasaki; C Lucas; L A Lasky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

9.  Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques.

Authors:  A Kaur; R M Grant; R E Means; H McClure; M Feinberg; R P Johnson
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Authors:  Julie M Decker; Kenneth P Zammit; Juliet L Easlick; Mario L Santiago; Denise Bonenberger; Beatrice H Hahn; Olaf Kutsch; Frederic Bibollet-Ruche
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.